Oleogel emulsion gels for controlled texture and stability
Oleogel emulsion gels embed oleogel droplets in a hydrocolloid hydrogel matrix to enable precise tuning of mechanical properties and sensory characteristics. The composite structure supports adjustable firmness and improved emulsion stability, with potential applications in food for enhanced mouthfeel and in pharmaceuticals where controlled ingredient release and stability are desired.
Overview
Oleogel emulsion gels are composite materials designed to enhance texture and stability. They integrate oleogel droplets within a hydrocolloid hydrogel matrix, enabling fine control over mechanical properties and sensory characteristics. This supports use cases where texture and stability are critical, including food formulations and pharmaceutical systems requiring controlled release and stability.
Technical specifications
The technology is based on dispersing oleogel droplets in a hydrocolloid hydrogel matrix. This architecture provides multiple parameters to tune mechanical performance and sensory attributes. Key features include:
- Tunable texture: Adjust firmness and consistency to match application needs.
- Enhanced stability: Improved emulsion stability enabled by the matrix structure.
- Versatile applications: Potential use in food products to improve mouthfeel and in pharmaceuticals for controlled ingredient release.
Technology readiness level
The technology is currently at a Technology Readiness Level (TRL) of 3, indicating laboratory validation. Further development and testing are expected to support progress toward commercial viability.
About University of South Australia
Formerly a comprehensive public research university based in Adelaide, UniSA operated multiple city and regional campuses; operations transitioned to the new Adelaide University on January 1, 2026, with an official opening on January 29, 2026. For industry, a one‑stop Enterprise Hub streamlined access to consulting, testing and bespoke training. Co‑located facilities in Adelaide BioMed City (including the UniSA Cancer Research Institute/Bradley Building) enabled close links with hospital partners, while the Mawson Lakes campus adjoined Technology Park to anchor defence and advanced‑technology collaborations. Research was consistently supported by competitive national funding from the Australian Research Council and the National Health and Medical Research Council, often alongside matched industry support. Commercialisation was backed by a dedicated technology transfer function and the Innovation & Collaboration Centre’s incubation and acceleration programs.
delivered to your inbox.